| Code | Description | Claims | Beneficiaries | Total Paid |
| 88377 |
|
1,403 |
493 |
$63K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
7,706 |
548 |
$36K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
690 |
507 |
$31K |
| 87481 |
|
1,805 |
382 |
$7K |
| 87529 |
|
1,197 |
490 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
270 |
188 |
$5K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
111 |
61 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
640 |
456 |
$3K |
| 87563 |
|
623 |
509 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
590 |
475 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
588 |
475 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
575 |
463 |
$2K |
| 88142 |
|
762 |
624 |
$2K |
| 88141 |
|
585 |
481 |
$2K |
| 87653 |
|
459 |
388 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
216 |
198 |
$1K |
| 87511 |
|
398 |
330 |
$1K |
| 80053 |
Comprehensive metabolic panel |
1,365 |
866 |
$1K |
| 87900 |
|
72 |
61 |
$261.01 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
12 |
$247.62 |
| 88312 |
|
23 |
23 |
$234.60 |
| 87640 |
|
71 |
41 |
$172.70 |
| 80061 |
Lipid panel |
839 |
683 |
$155.36 |
| 80050 |
General health panel |
561 |
483 |
$148.24 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
62 |
35 |
$142.80 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,478 |
989 |
$130.87 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
597 |
498 |
$107.40 |
| 82728 |
|
201 |
182 |
$72.62 |
| 83550 |
|
222 |
197 |
$60.49 |
| 87500 |
|
192 |
161 |
$58.00 |
| 82607 |
|
488 |
412 |
$46.33 |
| 84443 |
Thyroid stimulating hormone (TSH) |
325 |
221 |
$22.38 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
61 |
52 |
$19.42 |
| 84439 |
|
273 |
240 |
$17.39 |
| 82270 |
|
42 |
40 |
$14.65 |
| 83540 |
|
223 |
194 |
$13.18 |
| 84403 |
|
15 |
14 |
$12.11 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
795 |
653 |
$10.57 |
| 0853T |
|
116 |
70 |
$0.06 |
| 0831T |
|
58 |
54 |
$0.03 |
| 83880 |
|
281 |
128 |
$0.00 |
| 82746 |
|
34 |
28 |
$0.00 |
| 83735 |
|
239 |
201 |
$0.00 |
| 81001 |
|
135 |
68 |
$0.00 |
| 87486 |
|
41 |
18 |
$0.00 |
| 87498 |
|
17 |
14 |
$0.00 |
| 87088 |
|
27 |
12 |
$0.00 |
| 87581 |
|
41 |
18 |
$0.00 |
| 87541 |
|
41 |
18 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
34 |
14 |
$0.00 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
611 |
276 |
$0.00 |
| 88120 |
|
33 |
23 |
$0.00 |
| 0500T |
|
279 |
263 |
$0.00 |
| 84481 |
|
83 |
72 |
$0.00 |
| 88104 |
|
22 |
22 |
$0.00 |